The use of electronic nicotine delivery systems during pregnancy and the reproductive outcomes: A systematic review of the literature

Victor M Cardenas, Lori A Fischbach, Parimal Chowdhury, Victor M Cardenas, Lori A Fischbach, Parimal Chowdhury

Abstract

Introduction: Use of electronic nicotine delivery systems (ENDS) among pregnant women is of great concern. To our knowledge the current literature provides conflicting views regarding the uncertainties of the effects of ENDS use during pregnancy on the health of the fetus.

Methods: We searched PubMed, CINAHL, and EMBASE, for the period 2007 to October 2017 for terms to identify publications on ENDS use during pregnancy and the reproductive outcomes. We updated the search for the period November 2017 to November 2018 using Ovid Medline. We obtained full text of articles and present a summary of the contents.

Results: We found no studies of pregnant women exposed to ENDS use and its effect on their fetus or neonates. However, there is a growing body of experimental studies in animals that suggest that nicotine in ENDS alters DNA methylation, induces birth defects, reduces the birth weight, and affects the development of the heart and lungs of their offspring. A large population-based cohort study in the United States estimated that 5% of pregnant women were current ENDS users in 2014; most of them also smoked cigarettes. Surveys conducted among practitioners indicate that there is a need to screen and counsel pregnant women. Systematic reviews and meta-analysis of studies of women who used smokeless tobacco during pregnancy suggest that prenatal nicotine alone is a risk factor for low birth weight, premature delivery, and stillbirth.

Conclusions: There were no previous studies assessing the reproductive effects of ENDS use during pregnancy. However, prenatal exposure to nicotine is known to be harmful to the fetus and the pregnancy.

Keywords: electronic nicotine delivery systems (ENDS); pregnancy; prevalence; reproductive outcomes; risk.

Conflict of interest statement

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.

© 2019 Cardenas V.M.

Figures

Figure 1
Figure 1
Manuscript selection: Electronic Nicotine Delivery Systems use in pregnancy

References

    1. Cullen KA, Ambrose BK, Gentzke AS, Apelberg BJ, Jamal A, King BA. Notes from the field: Use of electronic cigarettes and any tobacco product among middle and high school students - United States, 2011-2018. MMWR Morb Mortal Wkly Rep. 2018;67(45):1276–1277. doi: 10.15585/mmwr.mm6745a5.
    1. Grana RA, Ling PM. ‘Smoking revolution’: A content analysis of electronic cigarette retail websites. Am J Prev Med. 2014;46(4):395–403. doi: 10.1016/j.amepre.2013.12.010.
    1. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P, 3rd, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: A longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160–167. doi: 10.1093/ntr/ntw160.
    1. Himes SK, Stroud LR, Scheidweiler KB, Niaura RS, Huestis MA. Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes. J Pediatr. 2013;162(5):970–975. doi: 10.1016/j.jpeds.2012.10.045.
    1. Holloway AC, Salomon A, Soares MJ, et al. Characterization of the adverse effects of nicotine on placental development: In vivo and in vitro studies. Am J Physiol Endocrinol Metab. 2014;306(4):E443–E456. doi: 10.1152/ajpendo.00478.2013.
    1. Committee opinion no 721 summary: Smoking cessation during pregnancy. Obstet Gynecol. 2017;130(4):929–930. doi: 10.1097/aog.0000000000002348.
    1. Public Health Consequences of E-Cigarettes. 1st ed. Washington, DC: The National Academies Press; 2018.
    1. Whittington JR, Simmons PM, Phillips AM, et al. The use of electronic cigarettes in pregnancy: A review of the literature. Obstet Gynecol Surv. 2018;73(9):544–549. doi: 10.1097/ogx.0000000000000595.
    1. Coleman T, Chamberlain C, Davey M, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews. 2015;(12):CD010078–CD010078. doi: 10.1002/14651858.CD010078.pub2.
    1. Cope G. How smoking during pregnancy affects the mother and fetus. Nurse Prescribing. 2015;13(6):282–286. doi: 10.12968/npre.2015.13.6.282.
    1. De Long NE, Barra NG, Hardy DB, Holloway AC. Is it safe to use smoking cessation therapeutics during pregnancy? Expert Opin Drug Saf. 2014;13(12):1721–1731. doi: 10.1517/14740338.2014.973846.
    1. Holbrook BD. The effects of nicotine on human fetal development. Birth Defects Res C Embryo Today. 2016;108(2):181–192. doi: 10.1002/bdrc.21128.
    1. Meernik C, Goldstein AO. A critical review of smoking, cessation, relapse and emerging research in pregnancy and post-partum. Br Med Bull. 2015;114(1):135–146. doi: 10.1093/bmb/ldv016.
    1. Suter MA, Mastrobattista J, Sachs M, Aagaard K. Is there evidence for potential harm of electronic cigarette use in pregnancy? Birth Defects Research. 2015;103(3):186–195. doi: 10.1002/bdra.23333.
    1. Wong MK, Barra NG, Alfaidy N, Hardy DB, Holloway AC. Adverse effects of perinatal nicotine exposure on reproductive outcomes. Reproduction. 2015;150(6):R185–R193. doi: 10.1530/rep-15-0295.
    1. McCubbin A, Fallin-Bennett A, Barnett J, Ashford K. Perceptions and use of electronic cigarettes in pregnancy. Health Educ Res. 2017;32(1):22–32. doi: 10.1093/her/cyw059.
    1. Li G, Saad S, Oliver BG, Chen H. Heat or burn? Impacts of intrauterine tobacco smoke and E- cigarette vapor exposure on the offspring’s health outcome. Toxics. 2018;6(3) doi: 10.3390/toxics6030043.
    1. Scherman A, Tolosa JE, McEvoy C. Smoking cessation in pregnancy: A continuing challenge in the United States. Therapeutic Advances in Drug Safety. 2018;9(8):457–474. doi: 10.1177/2042098618775366.
    1. Baraona LK, Lovelace D, Daniels JL, McDaniel L. Tobacco harms, nicotine pharmacology, and pharmacologic tobacco cessation interventions for women. J Midwifery Womens Health. 2017;62(3):253–269. doi: 10.1111/jmwh.12616.
    1. Nguyen T, Li GE, Chen H, Cranfield CG, McGrath KC, Gorrie CA. Maternal E-cigarette exposure results in cognitive and epigenetic alterations in offspring in a mouse model. Chem Res Toxicol. 2018;31(7):601–611. doi: 10.1021/acs.chemrestox.8b00084.
    1. Suter MA, Abramovici AR, Griffin E, et al. In utero nicotine exposure epigenetically alters fetal chromatin structure and differentially regulates transcription of the glucocorticoid receptor in a rat model. Birth Defects Research Part A-Clinical and Molecular Teratology. 2015;103(7):583–588. doi: 10.1002/bdra.23395.
    1. von Chamier M, Reyes L, Hayward LF, Brown MB. Impact of gestational nicotine exposure on intrauterine and fetal infection in a rodent model. Biol Reprod. 2017;96(5) doi: 10.1093/biolre/iox025.
    1. Palpant NJ, Hofsteen P, Pabon L, Reinecke H, Murry CE. Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettes. PLoS One. 2015;10(5):e0126259. doi: 10.1371/journal.pone.0126259.
    1. Chen H, Li G, Chan YL, et al. Maternal E-cigarette exposure in mice alters DNA methylation and lung cytokine expression in offspring. American Journal of Respiratory Cell & Molecular Biology. 2018;58(3):366–377. doi: 10.1165/rcmb.2017-0206rc.
    1. Chen H, Li G, Chan YL, et al. Modulation of neural regulators of energy homeostasis, and of inflammation, in the pups of mice exposed to e-cigarettes. Neurosci Lett. 2018;684:61–66. doi: 10.1016/j.neulet.2018.07.001.
    1. Kennedy AE, Kandalam S, Olivares-Navarrete R, Dickinson AJG. E-cigarette aerosol exposure can cause craniofacial defects in xenopus laevis embryos and mammalian neural crest cells. PLoS ONE. 2017;12(9):e0185729. doi: 10.1371/journal.pone.0185729.
    1. Kurti AN, Redner R, Lopez AA, et al. Tobacco and nicotine delivery product use in a national sample of pregnant women. Preventive Medicine. 2017;104:50–56. doi: 10.1016/j.ypmed.2017.07.030.
    1. Wagner NJ, Camerota M, Propper C. Prevalence and perceptions of electronic cigarette use during pregnancy. Maternal & Child Health Journal. 2017;21(8):1655–1661. doi: 10.1007/s10995-016-2257-9.
    1. Mark KS, Farquhar B, Chisolm MS, Coleman-Cowger VH, Terplan M. Knowledge, attitudes, and practice of electronic cigarette use among pregnant women. J Addict Med. 2015;9(4):266–272. doi: 10.1097/adm.0000000000000128.
    1. Bhandari NR, Day KD, Payakachat N, Franks AM, McCain KR, Ragland D. Use and risk perception of electronic nicotine delivery systems and tobacco in pregnancy. Womens Health Issues. 2018;28(3):251–257. doi: 10.1016/j.whi.2018.02.005.
    1. Ashford K, Rayens E, Wiggins AT, Rayens MK, Fallin A, Sayre MM. Advertising exposure and use of e-cigarettes among female current and former tobacco users of childbearing age. Public Health Nurs. 2017;34(5):430–436. doi: 10.1111/phn.12334.
    1. Oncken C, Ricci KA, Kuo CL, Dornelas E, Kranzler HR, Sankey HZ. Correlates of electronic cigarettes use before and during pregnancy. Nicotine Tob Res. 2017;19(5):585–590. doi: 10.1093/ntr/ntw225.
    1. Ashford K, Wiggins A, Butler K, Ickes M, Rayens MK, Hahn E. E-cigarette use and perceived harm among women of childbearing age who reported tobacco use during the past year. Nurs Res. 2016;65(5):408–414. doi: 10.1097/nnr.0000000000000176.
    1. Fallin A, Miller A, Assef S, Ashford K. Perceptions of electronic cigarettes among medicaid- eligible pregnant and postpartum women. J Obstet Gynecol Neonatal Nurs. 2016;45(3):320–325. doi: 10.1016/j.jogn.2016.02.009.
    1. England LJ, Tong VT, Koblitz A, Kish-Doto J, Lynch MM, Southwell BG. Perceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy. Prev Med Rep. 2016;4:481–485. doi: 10.1016/j.pmedr.2016.09.002.
    1. Stroud LR, Papandonatos GD, Borba K, Kehoe T, Scott-Sheldon LAJ. Flavored electronic cigarette use, preferences, and perceptions in pregnant mothers: A correspondence analysis approach. Addict Behav. 2019:91. doi: 10.1016/j.addbeh.2018.10.043.
    1. Kurti AN, Bunn JY, Villanti AC, et al. Patterns of single and multiple tobacco product use among US women of reproductive age. Nicotine Tobacco Res. 2018;20(suppl_1):S71–S80. doi: 10.1093/ntr/nty024.
    1. Kurti AN, Redner R, Bunn JY, et al. Examining the relationship between pregnancy and quitting use of tobacco products in a U.S. national sample of women of reproductive age. Prev Med. 2018;117:52–60. doi: 10.1016/j.ypmed.2018.08.019.
    1. England LJ, Anderson BL, Tong VT, et al. Screening practices and attitudes of obstetricians-gynecologists toward new and emerging tobacco products. Am J Obstet Gynecol. 2014;211(6):695.e1–695.e7. doi: 10.1016/j.ajog.2014.05.041.
    1. Northrup TF, Klawans MR, Villarreal YR, et al. Family physicians’ perceived prevalence, safety, and screening for cigarettes, marijuana, and electronic-nicotine delivery systems (ENDS) use during pregnancy. Journal of the American Board of Family Medicine: JABFM. 2017;30(6):743–757. doi: 10.3122/jabfm.2017.06.170183.
    1. Gould GS, Zeev YB, Tywman L, et al. Do Clinicians Ask Pregnant Women about Exposures to Tobacco and Cannabis Smoking, Second-Hand-Smoke and E-Cigarettes? An Australian National Cross-Sectional Survey. International Journal of Environmental Research & Public Health. 2017;14(12) doi: 10.3390/ijerph14121585.
    1. Giovino GA, Mirza SA, Samet JM, et al. Tobacco use in 3 billion individuals from 16 countries: An analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380(9842):668–679. doi: 10.1016/s0140-6736(12)61085-x.
    1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 89. Lyon, France: International Agency for Research on Cancer; 2007. Smokeless tobacco and some tobacco-specific N-nitrosamines; pp. 1–592. . Accessed December 4, 2018.
    1. Ratsch A, Bogossian F. Smokeless tobacco use in pregnancy: An integrative review of the literature. International Journal of Public Health. 2014;59(4):599–608. doi: 10.1007/s00038-014-0558-6.
    1. Inamdar AS, Croucher RE, Chokhandre MK, Mashyakhy MH, Marinho VCC. Maternal smokeless tobacco use in pregnancy and adverse health outcomes in newborns: A systematic review. Nicotine Tobacco Res. 2015;17(9):1058–1066. doi: 10.1093/ntr/ntu255.
    1. Suliankatchi RA, Sinha DN. The human cost of tobacco chewing among pregnant women in India: A systematic review and meta-analysis. Journal of Obstetrics & Gynaecology of India. 2016;66(Suppl 1):161–166. doi: 10.1007/s13224-015-0821-7.
    1. Amato MS, Boyle RG, Levy D. How to define e-cigarette prevalence? Finding clues in the use frequency distribution. Tob Control. 2016;25(e1):e24–e29. doi: 10.1136/tobaccocontrol-2015-052236.
    1. Pearson JL, Hitchman SC, Brose LS, et al. Recommended core items to assess e-cigarette use in population-based surveys. Tob Control. 2018;27(3):341–346. doi: 10.1136/tobaccocontrol-2016-053541.
    1. Weaver SR, Kim H, Glasser AM, et al. Establishing consensus on survey measures for electronic nicotine and non-nicotine delivery system use: Current challenges and considerations for researchers. Addict Behav. 2018;79:203–212. doi: 10.1016/j.addbeh.2017.11.016.
    1. Dietz PM, Homa D, England LJ, et al. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am J Epidemiol. 2011;173(3):355–359. doi: 10.1093/aje/kwq381.
    1. Schick SF, Blount BC, Jacob PR, et al. Biomarkers of exposure to new and emerging tobacco delivery products. Am J Physiol Lung Cell Mol Physiol. 2017;313(3):L425–L452. doi: 10.1152/ajplung.00343.2016.
    1. Chhabra D, Sharma S, Kho AT, et al. Fetal lung and placental methylation is associated with in utero nicotine exposure. Epigenetics. 2014;9(11):1473–1484. doi: 10.4161/15592294.2014.971593.
    1. Suter M, Abramovici A, Showalter L, et al. In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metabolism. 2010;59(10):1481–1490. doi: 10.1016/j.metabol.2010.01.013.
    1. Joubert BR, Felix JF, Yousefi P, et al. DNA methylation in newborns and maternal smoking in pregnancy: Genome-wide consortium meta-analysis. Am J Hum Genet. 2016;98(4):680–696. doi: 10.1016/j.ajhg.2016.02.019.
    1. Price EM, Penaherrera MS, Portales-Casamar E, et al. Profiling placental and fetal DNA methylation in human neural tube defects. Epigenetics Chromatin. 2016;9 doi: 10.1186/s13072-016-0054-8.
    1. Paneth N, Monk C. The importance of cohort research starting early in life to understanding child health. Curr Opin Pediatr. 2018;30(2):292–296. doi: 10.1097/mop.0000000000000596.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe